The prognosis for patients with head and neck tumors (HNSCC) is poor, due among other things to the high-risk factor for locoregional recurrence and/or second primary tumors. Extensive studies on chemoprevention of oral pre-cancers to stop carcinogenesis and to prevent recurrence and/or second primary tumors have failed to reach the desired effects. The toxicity of retinoids (RA) for example limits their dosage. Biomarkers are used to evaluate the duration of therapy. In this study, cell culture models are used to demonstrate immunocytochemical expression of RA receptors (RAR, RXR), Ki-67 and p53 before and after all-trans retinoic acid (ATRA) treatment. Telomerase activity in PCR is used to assess the effectiveness of ATRA. Along with an RA-sensitive HNSCC cell line UM-SCC-35 we employed cell lines UM-SCC-14C and HaCaT. Our immunocytochemical examination produced no proof of a statistically significant change in expression of RARα, RARβ or RXRγ receptors after ATRA treatment, either in the cells of the sensitive UM-SCC-35 line or in HaCaT cells. The RARβ and RXRγ receptors showed increased expression after brief cell treatment of UM-SCC-14C. The reduced telomerase activity after prolonged treatment of the UM-SCC-35-cells with ATRA (as well as the reduced p53 expression) proved to be a biomarker for evaluating the success of therapy. Although XTT and MTT tests demonstrated that cell proliferation in UM-SCC-35 cells was inhibited after brief and extended RA influence, the immunocytological Ki-67 scores failed to confirm the inhibition. No reduction of p53 expression, of telomerase activity or of cell proliferation in the XTT and MTT test was detected in the RA-insensitive cell line UM-SCC-14C or in HaCaT cells. We also demonstrated the parameters used in examining the models in sections of carcinoma tissue and in control tissues from the head and neck region, so they can be examined in clinical chemopreventive studies on biopsy tissue.

Download full-text PDF

Source
http://dx.doi.org/10.3892/ijo.2011.1139DOI Listing

Publication Analysis

Top Keywords

head neck
12
telomerase activity
12
cell
8
neck region
8
recurrence and/or
8
and/or second
8
second primary
8
primary tumors
8
atra treatment
8
um-scc-14c hacat
8

Similar Publications

Diabetes mellitus (DM) has been suggested as a potential risk factor for tinnitus, but evidence remains inconclusive. This meta-analysis aimed to evaluate the association between DM and tinnitus by systematically reviewing and synthesizing data from observational studies. A comprehensive literature search was conducted in PubMed, Embase, and Web of Science up to August 16, 2024.

View Article and Find Full Text PDF

Imaging Findings, Complications, and Mimics after Common and Advanced Dental Procedures.

Radiographics

February 2025

From the Department of Radiology, Nihon University School of Dentistry at Matsudo, 2-870-1 Sakaecho-Nishi, Matsudo, Chiba 271-8587, Japan (K.I., K.O., T.K.); Department of Diagnostic Radiology, National Cancer Center Hospital East, Chiba, Japan (H.K.); Department of Radiology, VA Boston Health Care System, Boston, Mass (V.C.A.A.); and Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Mass (O.S.).

Various new dental treatment methods have been introduced in dental clinics, and many new materials have been used in recent years for dental treatments. Dentistry is divided into several specialties, each offering unique treatments, such as endodontics, implantology, oral surgery, and orthodontics. CT and MR images after dental treatment reveal a variety of hard- and soft-tissue changes and dental materials, which often cause image artifacts.

View Article and Find Full Text PDF

Tympanostomy Tube With or Without Adenoidectomy-Reply.

JAMA Otolaryngol Head Neck Surg

January 2025

Department of Otolaryngology-Head & Neck Surgery, Stanford University School of Medicine, Division of Pediatric Otolaryngology, Lucile Packard Children's Hospital, Stanford, California.

View Article and Find Full Text PDF

Importance: Airway stenosis is a rare but debilitating disorder that significantly degrades the quality of life in affected patients. Treatments are primarily surgical, and disease management lacks established medical therapies. The North American Airway Collaborative held its third symposium at The Johns Hopkins Hospital in Baltimore, Maryland, on April 15, 2024, focused on strategies to advance the care of these patients.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!